This brand name is authorized in Austria, Australia, Brazil, Canada, Cyprus, France, Hong Kong, Croatia, Ireland, Malta, Mexico, Netherlands, New Zealand, Romania, Singapore, United Kingdom, United States, South Africa
The drug DULCOLAX contains one active pharmaceutical ingredient (API):
|
1
Bisacodyl
UNII 10X0709Y6I - BISACODYL
|
|
Bisacodyl is a locally acting laxative from the diphenylmethane derivatives group having a dual action. As a contact laxative, for which also antiresorptive hydragogue effects have been described, bisacodyl stimulates after hydrolysis in the large intestine, the mucosa of both the large intestine and of the rectum. Stimulation of the mucosa of the large intestine results in colonic peristalsis with promotion of accumulation of water, and consequently electrolytes, in the colonic lumen. This results in a stimulation of defecation, reduction of transit time and softening of the stool. Stimulation of the rectum causes increased motility and a feeling of rectal fullness. The rectal effect may help to restore the “call to stool” although its clinical relevance remains to be established. |
Below package inserts are available for further reading:
| Title | Information Source | Document Type | |
|---|---|---|---|
| DULCOLAX Gastro-resistant tablets | Medicines & Healthcare Products Regulatory Agency (GB) | MPI, EU: SmPC |
This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:
| ATC code | Group title | Classification |
|---|---|---|
| A06AB02 | Bisacodyl | A Alimentary tract and metabolism → A06 Laxatives → A06A Laxatives → A06AB Contact laxatives |
This drug has been assigned below unique identifiers within the countries it is being marketed:
| Country | Identification scheme | Identifier(s) |
|---|---|---|
| Country: AU | Pharmaceutical Benefits Scheme | Identifier(s): 10578R, 1260H, 3250C |
| Country: BR | Câmara de Regulação do Mercado de Medicamentos | Identifier(s): 576720050064617 |
| Country: CA | Health Products and Food Branch | Identifier(s): 00003875, 00254142, 02397854 |
| Country: FR | Base de données publique des médicaments | Identifier(s): 64835956, 65323898 |
| Country: GB | Medicines & Healthcare Products Regulatory Agency | Identifier(s): 107527, 135340, 135347, 19164, 30744, 30745 |
| Country: HK | Department of Health Drug Office | Identifier(s): 02708 |
| Country: MT | Medicines Authority | Identifier(s): MA1470/00401, MA1470/00402, MA1470/00501 |
| Country: MX | Comisión Federal para la Protección contra Riesgos Sanitarios | Identifier(s): 47191 |
| Country: NL | Z-Index G-Standaard, PRK | Identifier(s): 4960, 884 |
| Country: NZ | Medicines and Medical Devices Safety Authority | Identifier(s): 18027, 461, 463 |
| Country: RO | Agenția Națională a Medicamentului și a Dispozitivelor Medicale | Identifier(s): W68445001, W68446001 |
| Country: SG | Health Sciences Authority | Identifier(s): 02663P, 02668P, 02669P |
| Country: US | FDA, National Drug Code | Identifier(s): 41167-0101, 41167-0200, 41167-0210, 41167-0290, 41167-0400 |
| Country: ZA | Health Products Regulatory Authority | Identifier(s): E/11.5/531, E/11.5/532, E/11.5/534 |
© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.
